Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?

Background Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by barrier dysfunction and immune dysregulation, often leading to increased allergen penetration, sensitization, and secondary infections. Colloidal oat emollients are widely used in adult AD management, but the...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph F. Fowler, Lin Ma, James Bergman, Paul Horowitz, Tina Lavender, Lawrence F. Eichenfield, Zoe Draelos, Simon G. Danby, Michael J. Cork
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2025.2487945
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850122790518128640
author Joseph F. Fowler
Lin Ma
James Bergman
Paul Horowitz
Tina Lavender
Lawrence F. Eichenfield
Zoe Draelos
Simon G. Danby
Michael J. Cork
author_facet Joseph F. Fowler
Lin Ma
James Bergman
Paul Horowitz
Tina Lavender
Lawrence F. Eichenfield
Zoe Draelos
Simon G. Danby
Michael J. Cork
author_sort Joseph F. Fowler
collection DOAJ
description Background Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by barrier dysfunction and immune dysregulation, often leading to increased allergen penetration, sensitization, and secondary infections. Colloidal oat emollients are widely used in adult AD management, but their role in pediatric AD treatment, prevention, and allergy modulation remains under investigation.Methods A comprehensive literature review evaluated clinical and preclinical studies on colloidal oat-containing emollients in pediatric AD treatment and prevention. Studies assessing skin barrier function, immune modulation, AD prevention, food allergy risk, and healthcare utilization were included.Results Colloidal oat emollients improved skin hydration, reduced transepidermal water loss (TEWL), and supported barrier repair, leading to fewer AD flares and reduced reliance on steroid treatments. Studies suggest that early, consistent use of advanced emollient formulations may lower AD incidence in high-risk infants and reduce food sensitization rates. Real-world data indicate that patients using colloidal oat emollients have fewer clinic visits and lower overall healthcare costs. Concerns about oat sensitization remain unsubstantiated in most studies.Conclusion Colloidal oat emollients are effective, well-tolerated, and cost-efficient for pediatric AD management. Their barrier-restorative and anti-inflammatory properties may reduce AD and allergy risk. Future research should focus on head-to-head emollient comparisons to optimize treatment strategies.
format Article
id doaj-art-77a9f891e09147bb87552ee10c4eac76
institution OA Journals
issn 0954-6634
1471-1753
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj-art-77a9f891e09147bb87552ee10c4eac762025-08-20T02:34:46ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532025-12-0136110.1080/09546634.2025.2487945Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?Joseph F. Fowler0Lin Ma1James Bergman2Paul Horowitz3Tina Lavender4Lawrence F. Eichenfield5Zoe Draelos6Simon G. Danby7Michael J. Cork8Dermatology, University of Louisville School of Medicine, Louisville, Kentucky, USADermatology, Beijing Children’s Hospital, Beijing, ChinaDermatology, Bellevue, Washington, USAPediatrician, Children’s Hospital of Los Angeles, Los Angeles, California, USACentre for Childbirth, Women’s and Newborn Health Liverpool School of Tropical Medicine, Liverpool, UKDepartments of Dermatology and Pediatrics, University of California, San Diego and Rady Children’s Hospital, San Diego, California, USADermatology North Carolina, High Point, North Carolina, USASheffield Dermatology Research, Division of Clinical Medicine, University of Sheffield Medical School, Sheffield, UKSheffield Dermatology Research, University of Sheffield, Sheffield Children’s Hospital, Sheffield, UKBackground Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by barrier dysfunction and immune dysregulation, often leading to increased allergen penetration, sensitization, and secondary infections. Colloidal oat emollients are widely used in adult AD management, but their role in pediatric AD treatment, prevention, and allergy modulation remains under investigation.Methods A comprehensive literature review evaluated clinical and preclinical studies on colloidal oat-containing emollients in pediatric AD treatment and prevention. Studies assessing skin barrier function, immune modulation, AD prevention, food allergy risk, and healthcare utilization were included.Results Colloidal oat emollients improved skin hydration, reduced transepidermal water loss (TEWL), and supported barrier repair, leading to fewer AD flares and reduced reliance on steroid treatments. Studies suggest that early, consistent use of advanced emollient formulations may lower AD incidence in high-risk infants and reduce food sensitization rates. Real-world data indicate that patients using colloidal oat emollients have fewer clinic visits and lower overall healthcare costs. Concerns about oat sensitization remain unsubstantiated in most studies.Conclusion Colloidal oat emollients are effective, well-tolerated, and cost-efficient for pediatric AD management. Their barrier-restorative and anti-inflammatory properties may reduce AD and allergy risk. Future research should focus on head-to-head emollient comparisons to optimize treatment strategies.https://www.tandfonline.com/doi/10.1080/09546634.2025.2487945Colloidal oatatopic dermatitisinfantatopic dermatitis in infantscolloidal oat emollientprevention of atopic dermatitis
spellingShingle Joseph F. Fowler
Lin Ma
James Bergman
Paul Horowitz
Tina Lavender
Lawrence F. Eichenfield
Zoe Draelos
Simon G. Danby
Michael J. Cork
Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
Journal of Dermatological Treatment
Colloidal oat
atopic dermatitis
infant
atopic dermatitis in infants
colloidal oat emollient
prevention of atopic dermatitis
title Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
title_full Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
title_fullStr Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
title_full_unstemmed Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
title_short Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
title_sort is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants
topic Colloidal oat
atopic dermatitis
infant
atopic dermatitis in infants
colloidal oat emollient
prevention of atopic dermatitis
url https://www.tandfonline.com/doi/10.1080/09546634.2025.2487945
work_keys_str_mv AT josephffowler iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT linma iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT jamesbergman iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT paulhorowitz iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT tinalavender iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT lawrencefeichenfield iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT zoedraelos iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT simongdanby iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants
AT michaeljcork iscolloidaloataneffectiveemollientingredientforthepreventionandtreatmentofatopicdermatitisininfants